Team Design Project Presentation Day 2023 - Keck Graduate Institute April 21, 2023, 8:30 am Skip to main content
Loading Events

« All Events

  • This event has passed.
Collage 2 TDP

The Team Design Project (TDP) Presentation Day is the capstone project for KGI’s Master of Engineering in Biopharmaceutical Processing (MEng) program. TDP Day is an in-person event this year.  Master of Engineering Teams will be presenting their capstone project designs developing the next generation of biomanufacturing facilities for the future biopharmaceutical industry.

Friday, April 21, 2023
8:30 a.m. – 5:00 p.m.
517 Building, Room 165 (Founder’s Room) | Maps and Parking

  • Mike Alston
    Mike Alston, Jr.
    Vice President, Operations, Avid Bioservices

    Michael Alston Jr. currently serves as the Vice President of Operations for Avid Bioservices and is responsible for CGMP manufacturing operations, technical operations, facilities, engineering, and environmental health and safety.

    Mr. Alston has over 15 years of CGMP operations experience in the biopharmaceutical, biotechnology, and food manufacturing industries. This includes leading all phases of process and facility design, development, and optimization. He received his bachelor’s degree in Electrical Engineering from the California State University, Fullerton (CSUF), and a graduate certificate in Project Management from Lehigh University.

    Prior to this role, Mr. Alston held positions of increasing scope and responsibility for ConAgra Foods, Merck & Co., Inc., Unilever, and Sterogene Bioseparations in manufacturing, engineering, continuous improvement, and maintenance. Additionally, he led Avid’s $150+ million capital investment portfolio for expansions at its’ Tustin and Costa Mesa facilities.


    Angel Webb 2
    Angel Webb, MEng ’21
    Engineer II, CQV at IPS-Integrated Project Services

    “The Role of Qualification and Validation in Delivering Operational Capacity”

    Ms. Webb has over 3 years of experience in biopharmaceutical engineering, quality assurance, and validation services. Angel’s background includes commissioning, qualification, and quality control document generation and execution within cGMP compliant environments, as well as extensive hands-on knowledge of mammalian cell culturing and downstream purification.

  • Team 1:  STEM&M Bio

    “Kiepjinchymal- An Allogeneic Bone Marrow-Derived Stem Cell Treatment for Moderate to Severe Crohn’s Disease.”


    Kiepjinchymal is an allogeneic bone marrow-derived naïve mesenchymal stem cell (BM-MSCs) product indicated for moderate to severe Crohn’s Disease. It targets those with Crohn’s Disease who have become unresponsive to conventional treatments and need surgery. Kiepjinchymal has the possibility to be a one-time treatment in contrast to invasive surgery that is a temporary solution to Crohn’s Disease.

    Team 2:  AAVALANCHE THERAPEUTICS: Winter is Coming

    “EFIXIV-GT: The Effective Treatment Option for Hemophilia B”


    AAVALANCHE Therapeutics introduces our pipeline product EFIXIV-GT, a novel adeno-associated virus (AAV) based gene therapy carrying a functional copy of the Factor IX gene. A Baculovirus expression vector (BEV) along with an insect cell line (SF9) will be used to produce the recombinant adeno associated virus (rAAV).  This gene therapy will provide a long-lasting treatment option for males ages 20-44 who have moderate to severe Hemophilia B. With EFIXIV-GT, AAVALANCHE Therapeutics is dedicated to transforming the lives of patients with rare diseases through science, teamwork, and a commitment to excellence. 

  • (Subject to change. Final agenda will be sent out the day before the event)

    8:30 a.m.
    Check-In & Networking
    9:00 a.m.
    Welcome & Opening Remarks
    9:30 – 10:15 a.m.
    Keynote Speaker
    10:15 a.m. – 12:00 p.m.
    Morning Session Team Presentations
    12:00 – 12:10 p.m.
    Group Photos
    12:10 – 1:30 p.m.
    LUNCH & Poster Session
    1:30 – 3:15 p.m.
    Afternoon Session Team Presentations
    3:15 – 4:00 p.m.
    Panel Discussion
    4:00 p.m.


April 21, 2023
8:30 am - 5:00 pm PDT
Event Categories:


Bioprocessing and MEng